BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 8.94 billion as of April 24, 2025. Its market cap has decreased by -31.31% in one year.

Market Cap

8.94B

Enterprise Value

8.56B

Revenue

2.28B

Ranking

n/a

PE Ratio

26.23

Stock Price

62.28

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.94B, an increase of 3,051.18%. That is a compound annual growth rate of 14.33%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	8.94B	-10.64%
Dec 31, 2024	10.01B	-29.83%
Dec 29, 2023	14.26B	-10.67%
Dec 30, 2022	15.96B	33.26%
Dec 31, 2021	11.98B	2.74%
Dec 31, 2020	11.66B	1.67%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	157.23B
GSK plc	55.19B
Haleon	34.87B
Smith & Nephew	8.58B
ConvaTec Group	5.21B
Hikma Pharmaceuticals	4.15B
HUTCHMED (China)	2.01B
Oxford Nanopore Technologies	1.13B

Market Cap Rankings